EUVIMEDEUVIMED entdecken
Crossref

Cell-free DNA methylation profiling in early-onset preeclampsia using methylated DNA sequencing

M M van Vliet, R G Boers, R J H Galjaard, J B Boers, R P M Steegers-Theunissen, J Gribnau, S Schoenmakers

Placenta · 2026

DOI: 10.1016/j.placenta.2025.12.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Placenta, 2026. Verfasst von M M van Vliet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Erasmus MC, Rotterdam, 3015CN, the Netherlands; Department of Developmental Biology, Erasmus MC, Rotterdam, …. Hauptthemen laut MEDLINE: Pre-Eclampsia, DNA Methylation, Cell-Free Nucleic Acids. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Non-US Government Research Support type.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Distinct DNA methylation profiles have been identified in maternal plasma cell-free DNA (cfDNA) in early-onset preeclampsia (EOPE). However, findings across studies often lack concordance and the biological mechanisms driving methylation differences are largely unknown. We aimed to identify EOPE-associated differentially methylated regions (DMRs), investigate changes in tissue-specific cfDNA contributions and validate previously reported EOPE-associated regions. METHODS: First-trimester cfDNA (n = 35) and cfDNA after diagnosis (n = 21) were collected from EOPE pregnancies and matched-controls. Placental tissues were collected from EOPE (n = 5) and control (n = 7) pregnancies. MeD-seq assays were performed to identify DMRs. Placental-contribution to cfDNA, cfDNA concentration, EOPE-specific placental markers, and methylation levels at previously identified EOPE-associated regions were compared between cases and controls. Additionally, liver-, kidney-, and endothelium-specific hypermethylated regions were identified using publicly available datasets and compared in cfDNA. RESULTS: We identified one DMR in the first trimester and 249 DMRs in our after diagnosis cohort. Total cfDNA concentration was 20-fold higher after EOPE diagnosis compared to controls (p < 0.001). We identified 606 DMRs in EOPE placentas, which unexpectedly were almost not present in cfDNA after EOPE diagnosis. Also, the placental-, liver-, and kidney-specific contributions were relatively decreased, while endothelium-specific methylation was increased. Only 2.7-8.4 % of previously identified regions showed significant differential methylation in our cohort. DISCUSSION: Differential tissue contributions to cfDNA likely account for DMRs identified after EOPE diagnosis. Further research is required to clarify the (tissue) origins of identified cfDNA DMRs in more detail. Lack of concordance across studies remains a significant limitation, potentially explained by methodological heterogeneity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaDNA MethylationCell-Free Nucleic AcidsHumansFemalePregnancyAdultPlacentaPregnancy Trimester, FirstSequence Analysis, DNACase-Control Studies

Stichwörter der Autor:innen

Cell-free DNADNA methylationPlacentaPreeclampsia

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Erasmus MC, Rotterdam, 3015CN, the Netherlands; Department of Developmental Biology, Erasmus MC, Rotterdam, 3015CN, the Netherlands.
  • Department of Developmental Biology, Erasmus MC, Rotterdam, 3015CN, the Netherlands.
  • Department of Clinical Genetics, Erasmus Medical Centre Rotterdam, Rotterdam, 3015CN, the Netherlands.
  • Department of Obstetrics and Gynecology, Erasmus MC, Rotterdam, 3015CN, the Netherlands.
  • Department of Obstetrics and Gynecology, Erasmus MC, Rotterdam, 3015CN, the Netherlands. Electronic address: s.schoenmakers@erasmusmc.nl.

Förderung

  • Non-US Government Research Support type

Zitieren

APA

van Vliet, M. M., Boers, R. G., Galjaard, R. J. H., Boers, J. B., Steegers-Theunissen, R. P. M., Gribnau, J., & Schoenmakers, S. (2026). Cell-free DNA methylation profiling in early-onset preeclampsia using methylated DNA sequencing. Placenta. https://doi.org/10.1016/j.placenta.2025.12.006

Vancouver

van Vliet MM, Boers RG, Galjaard RJH, Boers JB, Steegers-Theunissen RPM, Gribnau J, et al. Cell-free DNA methylation profiling in early-onset preeclampsia using methylated DNA sequencing. Placenta. 2026. doi:10.1016/j.placenta.2025.12.006

BibTeX
@article{vanVliet2026,
  author = {van Vliet, M M and Boers, R G and Galjaard, R J H and Boers, J B and Steegers-Theunissen, R P M and Gribnau, J and Schoenmakers, S},
  title = {Cell-free DNA methylation profiling in early-onset preeclampsia using methylated DNA sequencing},
  journal = {Placenta},
  year = {2026},
  doi = {10.1016/j.placenta.2025.12.006}
}
Kostenlos starten →